Fractyl Health (GUTS) Tests Whether Revita Can Redefine Post-GLP-1 Weight Maintenance Economics [Yahoo! Finance]
Fractyl Health, Inc. (GUTS)
Company Research
Source: Yahoo! Finance
procedure for weight maintenance after GLP-1 drug discontinuation, and is seeking FDA feedback on a potential De Novo regulatory pathway. The company has laid out a packed 2026 roadmap of clinical readouts and regulatory milestones for Revita, signaling a clearer path toward potential U.S. marketing submission in post-GLP-1 weight maintenance. We will now examine how the encouraging REMAIN-1 Midpoint data and De Novo pathway discussions could reshape Fractyl Health's investment narrative. The latest GPUs need a type of rare earth metal called Dysprosium and there are only 33 companies in the world exploring or producing it . Find the list for free. To own Fractyl Health, you have to believe Revita can earn a meaningful role in post-GLP-1 weight maintenance and that the company can finance itself long enough to reach that point. The new six-month REMAIN-1 Midpoint data and the request to move Revita onto a De Novo pathway materially sharpen the near-term story: 2026 is now more
Show less
Read more
Impact Snapshot
Event Time:
GUTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GUTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GUTS alerts
High impacting Fractyl Health, Inc. news events
Weekly update
A roundup of the hottest topics
GUTS
News
- Fractyl Health (GUTS) had its "buy" rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $8.00 price target on the stock.MarketBeat
- Fractyl Health Inc (GUTS) Q4 2025 Earnings Call Highlights: Navigating Financial Challenges ... [Yahoo! Finance]Yahoo! Finance
- Fractyl Health Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Fractyl Health Reports Fourth Quarter and Full Year 2025 Financial Results and Business UpdatesGlobeNewswire
- H.C. Wainwright Maintains a Buy Rating on Fractyl Health, Inc. (GUTS) with an $8 Price Target [Yahoo! Finance]Yahoo! Finance
GUTS
Sec Filings
- 3/24/26 - Form 10-K
- 3/24/26 - Form 8-K
- 3/17/26 - Form 8-K
- GUTS's page on the SEC website